BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
94 hedge funds and large institutions have $85.1M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $85K | Put options by funds: $95K
Holders
94
Holding in Top 10
–
Calls
$85K
Puts
$95K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$3.58M | |
| 3 | +$1.8M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.17M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$926K |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$2.84M | |
| 3 | -$943K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$227K |
| 5 |
BlackRock
New York
|
-$206K |